TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive NCI Denies GAO Report That Backlog Still Exists, Says Most were Published As Research Results May 18, 1979
TCL Archive NCCN in Transition: New Strategy to Examine Role of Informatics, Revenue Sources and International Programs June 15, 2012